Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status

Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status

Tofacitinib is an oral, small-molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We summarize the efficacy and safety data of tofacitinib 5 or 10 mg twice daily in the UC clinical program, stratified by prior tumor necrosis factor inhibitor (TNFi) failure status.Efficacy w...

Full description

Saved in:
Bibliographic Details
Main Authors: William J. Sandborn, Laurent Peyrin–Biroulet, Ala I. Sharara, Chinyu Su, Irene Modesto, Rajiv Mundayat, Levent Mert Günay, Leonardo Salese, Bruce E. Sands
Format: Artigo
Language:English
Published: 2021
Online Access:https://doi.org/10.1016/j.cgh.2021.02.043
http://www.cghjournal.org/article/S1542356521002226/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1016/j.cgh.2021.02.043
http://www.cghjournal.org/article/S1542356521002226/pdf

Similar Items